Impact (REF3a/b)

Impact template (REF3a)

Download template (74K)

All impact case studies

Download all case studies (2.2MB)

Individual case studies

Building and Implementing a Replicable Model for HIV Testing and Counselling (140K)

Changing Clinical Practice from Imatinib to Nilotinib in Chronic Myeloid Leukaemia (CML) (49K)

Control of Japanese Encephalitis (48K)

Development of an Effective Cure for River Blindness (Onchocerciasis) and Elephantiasis (Lymphatic Flariasis [LF]) and a New Tool for Control, Elimination and Morbidity Management (125K)

Development of Novel Tamponade Agents has Improved the Treatment of Retinal Detachment (183K)

Diagnostic Tests for Cystic Fibrosis Epidemic Strains (189K)

HLA Alleles as Genetic Predictors for Drug-Induced Hypersensitivity Reactions (127K)

Improved Inflammatory Bowel Disease Treatment by Reducing Unsafe Corticosteroid Use (161K)

Improved Management of Hereditary and Chronic Pancreatitis (45K)

Improving Meningococcal Disease Diagnosis (178K)

Improving the Impact of Malaria Prevention Activities (176K)

Malarial Retinopathy has Redefined the Diagnosis of Cerebral Malaria and Improved the Management of Coma in African Children (272K)

Rotavirus Vaccine Evaluation and Introduction in Africa (80K)

Sepsis Diagnostic & Company Spin-out (63K)

The Epidemiology and Control of Malaria in Pregnancy (168K)

The Evidence-Based Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease (COPD) (230K)

The Liverpool Diabetic Eye Study has set the standard for screening for sight-threatening diabetic retinopathy in the UK and Europe (173K)

Therapeutic Drug Monitoring for HIV drugs (50K)